Malignant melanoma and Thyroxine decreased

---

Gender of people who have Malignant Melanoma and experienced Thyroxine Decreased *:

• female: 12.5 %
• male: 87.5 %

Age of people who have Malignant Melanoma and experienced Thyroxine Decreased *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 0.0 %
• 30-39: 6.25 %
• 40-49: 25.0 %
• 50-59: 50.0 %
• 60+: 18.75 %

Common co-existing conditions for these people *:

1. Malaise (a feeling of general discomfort or uneasiness): 2 people, 12.50%
2. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 12.50%
3. Thyroid Diseases: 1 person, 6.25%
4. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 6.25%

Common drugs taken by these people *:

1. Yervoy: 8 people, 50.00%
2. Metastron: 5 people, 31.25%
3. Decadron: 5 people, 31.25%
4. Opdivo: 3 people, 18.75%
5. Trintellix: 2 people, 12.50%
6. Synthroid: 2 people, 12.50%
7. Keytruda: 2 people, 12.50%
8. Zoloft: 1 person, 6.25%
9. Pregabalin: 1 person, 6.25%
10. Omeprazole: 1 person, 6.25%

Common symptoms for these people *:

1. Nausea (feeling of having an urge to vomit): 13 people, 81.25%
2. Diarrhea: 9 people, 56.25%
3. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 9 people, 56.25%
4. Blood Thyroid Stimulating Hormone Decreased: 8 people, 50.00%
5. Tri-Iodothyronine Decreased: 8 people, 50.00%
6. Fever: 7 people, 43.75%
7. Headache (pain in head): 7 people, 43.75%
8. Malaise (a feeling of general discomfort or uneasiness): 6 people, 37.50%
9. Anaemia (lack of blood): 6 people, 37.50%
10. Fatigue (feeling of tiredness): 6 people, 37.50%

Do you take medications and have Thyroxine decreased?

- Check whether Thyroxine decreased is associated with a drug or a condition